Cargando…

Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis

Although treatment of multiple sclerosis (MS) with the type I interferon (IFN) IFN-β lowers disease activity, the role of endogenous type I IFN in MS remains controversial. We studied CD4+ T cells and CD4+ T cell subsets, monocytes and dendritic cells by flow cytometry and analysed the relationship...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sellebjerg, Finn, Krakauer, Martin, Limborg, Signe, Hesse, Dan, Lund, Henrik, Langkilde, Annika, Søndergaard, Helle Bach, Sørensen, Per Soelberg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368920/ https://www.ncbi.nlm.nih.gov/pubmed/22701554 http://dx.doi.org/10.1371/journal.pone.0035927

Ejemplares similares

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
por: Romme Christensen, Jeppe, et al.
Publicado: (2012)

Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
por: Börnsen, Lars, et al.
Publicado: (2015)

Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis
por: Börnsen, Lars, et al.
Publicado: (2012)

Pulsed immune reconstitution therapy in multiple sclerosis
por: Sorensen, Per Soelberg, et al.
Publicado: (2019)

Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls
por: Olsson, Anna, et al.
Publicado: (2021)

Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis
por: Lund, Henrik, et al.
Publicado: (2013)

Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls
por: Buhelt, Sophie, et al.
Publicado: (2019)

Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis
por: Søndergaard, Helle Bach, et al.
Publicado: (2021)

IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8(+) T Cells
por: Buhelt, Sophie, et al.
Publicado: (2021)

Progressive multiple sclerosis, cognitive function, and quality of life
por: Højsgaard Chow, Helene, et al.
Publicado: (2018)

Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Christensen, Jeppe Romme, et al.
Publicado: (2013)

Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis
por: Dogonowski, Anne-Marie, et al.
Publicado: (2016)

Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Romme Christensen, Jeppe, et al.
Publicado: (2013)

The gut microbiota in multiple sclerosis varies with disease activity
por: Thirion, Florence, et al.
Publicado: (2023)

IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis
por: von Essen, Marina R., et al.
Publicado: (2019)

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration
por: Subhi, Yousif, et al.
Publicado: (2019)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
por: Hegen, Harald, et al.
Publicado: (2016)

Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis
por: Carrión, Belinda, et al.
Publicado: (2021)

The Danish Multiple Sclerosis Treatment Register
por: Magyari, Melinda, et al.
Publicado: (2016)

The Etiology of Multiple Sclerosis: Genetic Evidence for the Involvement of the Human Endogenous Retrovirus HERV-Fc1
por: Nexø, Bjørn A., et al.
Publicado: (2011)

Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial
por: Højsgaard Chow, Helene, et al.
Publicado: (2021)

The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey
por: Gustavsen, S., et al.
Publicado: (2021)

The Multiple Sclerosis Care Unit
por: Soelberg Sorensen, Per, et al.
Publicado: (2018)

The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement
por: Hedström, Anna Karin, et al.
Publicado: (2017)

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis
por: Bachelet, Delphine, et al.
Publicado: (2016)

Variation in NOD2 Augments Th2- and Th17 Responses to Myelin Basic Protein in Multiple Sclerosis
por: Hedegaard, Chris Juul, et al.
Publicado: (2011)

The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis
por: Hasselbalch, IC, et al.
Publicado: (2018)

Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis
por: Filikci, Zuhal, et al.
Publicado: (2022)

Involvement of the endogenous retroviral locus HERV-Fc1 on the human X-chromosome in multiple sclerosis
por: Nexø, Bjørn A, et al.
Publicado: (2011)

Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis
por: Andersen, Johanna Balslev, et al.
Publicado: (2022)

The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of cancer in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Multiple sclerosis impairs regional functional connectivity in the cerebellum()
por: Dogonowski, Anne-Marie, et al.
Publicado: (2013)

Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry
por: Nørgaard, Mette, et al.
Publicado: (2021)

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results
por: Link, Jenny, et al.
Publicado: (2017)

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

The relation between inflammation and neurodegeneration in multiple sclerosis brains
por: Frischer, Josa M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_m6opn454quqtbojcidmgvkqs4f